New research indicates that statin use is associated with a significantly lower risk of developing intestinal strictures in patients with Crohn’s disease. The study suggests that the anti-inflammatory and antifibrotic properties of statins may help prevent the structural damage that often leads to surgical intervention.

Use of statins after the diagnosis of Crohn’s disease is associated with a lower risk for intestinal stricture formation than the use of other non-statin drugs.